These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21035886)

  • 1. The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients.
    Takao T; Ide T; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    Diabetes Res Clin Pract; 2011 Feb; 91(2):e40-2. PubMed ID: 21035886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up.
    Takao T; Ide T; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    Diabetes Res Clin Pract; 2010 Sep; 89(3):296-302. PubMed ID: 20416966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes?
    Zoppini G; Verlato G; Targher G; Casati S; Gusson E; Biasi V; Perrone F; Bonora E; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):334-9. PubMed ID: 18571393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal cutoff values of fasting plasma glucose (FPG) variability for detecting retinopathy and the threshold of FPG levels for predicting the risk of retinopathy in type 2 diabetes: A longitudinal study over 27 years.
    Takao T; Inoue K; Suka M; Yanagisawa H; Iwamoto Y
    Diabetes Res Clin Pract; 2018 Jun; 140():228-235. PubMed ID: 29625141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes: A systematic review and meta-analysis.
    Zhao Q; Zhou F; Zhang Y; Zhou X; Ying C
    Diabetes Res Clin Pract; 2019 Feb; 148():23-31. PubMed ID: 30583033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes diagnostic thresholds of the glycated hemoglobin A1c and fasting plasma glucose levels considering the 5-year incidence of retinopathy.
    Nakagami T; Takahashi K; Suto C; Oya J; Tanaka Y; Kurita M; Isago C; Hasegawa Y; Ito A; Uchigata Y
    Diabetes Res Clin Pract; 2017 Feb; 124():20-29. PubMed ID: 28081449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Accuracy of Diagnostic Methods for Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
    Martínez-Vizcaíno V; Cavero-Redondo I; Álvarez-Bueno C; Rodríguez-Artalejo F
    PLoS One; 2016; 11(4):e0154411. PubMed ID: 27123641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EFFECTS OF GLYCEMIC VARIABILITY ON THE PROGRESSION OF DIABETIC RETINOPATHY AMONG PATIENTS WITH TYPE 2 DIABETES.
    Park JY; Hwang JH; Kang MJ; Sim HE; Kim JS; Ko KS
    Retina; 2021 Jul; 41(7):1487-1495. PubMed ID: 33252581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma
    Jiang Q; Lyu XM; Yuan Y; Wang L
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28108673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%.
    Wang C; Song J; Ma Z; Yang W; Li C; Zhang X; Hou X; Sun Y; Lin P; Liang K; Gong L; Wang M; Liu F; Li W; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Chen L
    PLoS One; 2014; 9(7):e102941. PubMed ID: 25047354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes.
    Tang X; Zhong J; Zhang H; Luo Y; Liu X; Peng L; Zhang Y; Qian X; Jiang B; Liu J; Li S; Chen Y
    Cardiovasc Diabetol; 2019 Apr; 18(1):50. PubMed ID: 30992008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients.
    Gimeno-Orna JA; Castro-Alonso FJ; Boned-Juliani B; Lou-Arnal LM
    J Diabetes Complications; 2003; 17(2):78-81. PubMed ID: 12614973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison in the ability to detect diabetic retinopathy between fasting plasma glucose and HbA1c levels in a longitudinal study.
    Matsushita Y; Yokoyama T; Takeda N; Katai N; Yoshida-Hata N; Nakamura Y; Yamamoto S; Noda M; Mizoue T; Nakagawa T
    Endocrinol Diabetes Metab; 2021 Jan; 4(1):e00196. PubMed ID: 33532623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8-year prospective cohort study.
    Hsieh YT; Hsieh MC
    Clin Exp Ophthalmol; 2020 May; 48(4):470-476. PubMed ID: 32065699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic association of newly diagnosed proliferative diabetic retinopathy among type 2 diabetes patients presented at a tertiary eye hospital of Nepal.
    Thapa R; Bajimaya S; Sharma S; Rai BB; Paudyal G
    Nepal J Ophthalmol; 2015; 7(1):26-32. PubMed ID: 26695602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclassification of preproliferative diabetic retinopathy and glycemic control: relationship between mean hemoglobin A1C value and development of proliferative diabetic retinopathy.
    Sato Y; Lee Z; Hayashi Y
    Jpn J Ophthalmol; 2001; 45(5):523-7. PubMed ID: 11583677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic variability and diabetes retinopathy: a missing link.
    Hsu CR; Chen YT; Sheu WH
    J Diabetes Complications; 2015 Mar; 29(2):302-6. PubMed ID: 25534877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between diabetic retinopathy, glycemic control, risk factor indicators and patient education.
    Axer-Siegel R; Herscovici Z; Gabbay M; Mimouni K; Weinberger D; Gabbay U
    Isr Med Assoc J; 2006 Aug; 8(8):523-6. PubMed ID: 16958239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
    Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the long-term durability and glycemic control of fasting plasma glucose and glycosylated hemoglobin for pioglitazone in Japanese patients with type 2 diabetes.
    Stringer F; DeJongh J; Enya K; Koumura E; Danhof M; Kaku K
    Diabetes Technol Ther; 2015 Mar; 17(3):215-23. PubMed ID: 25531677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.